Cargando…
Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases
BACKGROUND: Patients with coronavirus disease 2019 (COVID-19) and underlying cardiovascular comorbidities have poor prognoses. Our aim was to identify the impact of serum lactate dehydrogenase (LDH), which is associated with mortality in acute respiratory distress syndrome, on the prognoses of patie...
Autores principales: | Masumoto, Akiko, Kitai, Takeshi, Matsumoto, Shingo, Kuroda, Shunsuke, Kohsaka, Shun, Tachikawa, Ryo, Seo, Ryutaro, Doi, Asako, Tomii, Keisuke, Yonetsu, Taishi, Torii, Sho, Komuro, Issei, Hirata, Ken-ichi, Node, Koichi, Matsue, Yuya, Furukawa, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese College of Cardiology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712257/ https://www.ncbi.nlm.nih.gov/pubmed/35000825 http://dx.doi.org/10.1016/j.jjcc.2021.12.014 |
Ejemplares similares
-
External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors
por: Kuroda, Shunsuke, et al.
Publicado: (2021) -
Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry()
por: Shibahashi, Eiji, et al.
Publicado: (2022) -
Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection
por: Saito, Takafumi, et al.
Publicado: (2022) -
Sex Differences in Clinical Outcomes Among Patients With COVID-19 and Cardiovascular Disease ― Insights From the CLAVIS-COVID Registry ―
por: Matsumoto, Shingo, et al.
Publicado: (2022) -
Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
por: Kitakata, Hiroki, et al.
Publicado: (2021)